384 filings
Page 3 of 20
8-K
4putgbx96 6r
3 Dec 19
Departure of Directors or Certain Officers
4:16pm
8-K
snd8zqgaqni5 jatm
15 Nov 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
hp2qk
7 Nov 19
Savara Reports Third Quarter 2019 Financial Results
4:06pm
8-K
qfhvmu34v 59ssrx
2 Oct 19
Regulation FD Disclosure
8:11am
8-K
gpcdzzhi 3wdxm2cwr
8 Aug 19
Savara Reports Second Quarter 2019 Financial Results
4:21pm
8-K
qbmagqy1mmzs7bbr
27 Jun 19
Entry into a Material Definitive Agreement
4:06pm
8-K
8k78w7
12 Jun 19
Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment
4:13pm
8-K
y2fkv8
31 May 19
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
ba1fez
28 May 19
Entry into a Material Definitive Agreement
4:25pm
8-K
r336m 77xb8xd
9 May 19
Savara Reports First Quarter 2019 Financial Results
4:10pm
8-K
ut0lpspn9a5o 9i72p
30 Apr 19
Entry into a Material Definitive Agreement
4:10pm
8-K
9xy80 y49
15 Apr 19
Changes in Registrant's Certifying Accountant
4:40pm
8-K
6r0g44wkuk2u5twe
3 Apr 19
Changes in Registrant's Certifying Accountant
4:10pm
8-K
9ya47oq qqzv5s9kibv
13 Mar 19
Savara Reports Fourth Quarter and Full Year 2018 Financial Results
4:14pm
8-K
8ln8jfq9mjbuev8jlat9
19 Dec 18
Savara Announces Interim Results for Optima Clinical Study
8:26am
8-K
wf2qa9qg nn
14 Dec 18
Departure of Directors or Certain Officers
4:05pm
8-K
9fqu w0a6o1njg
7 Dec 18
Entry into a Material Definitive Agreement
4:06pm
8-K
shxp8xj95uz
7 Nov 18
Savara Reports Third Quarter 2018 Financial Results
4:12pm
8-K
n7ni2m3
9 Aug 18
Savara Reports Second Quarter 2018 Financial Results
4:08pm
8-K
9kfx53fh ow18qy
6 Aug 18
Departure of Directors or Certain Officers
12:00am